Cerus Current Ratio 2010-2025 | CERS

Cerus current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cerus Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-03-31 $0.16B $0.07B 2.32
2024-12-31 $0.15B $0.06B 2.39
2024-09-30 $0.14B $0.05B 2.59
2024-06-30 $0.14B $0.05B 2.51
2024-03-31 $0.14B $0.06B 2.41
2023-12-31 $0.14B $0.07B 2.14
2023-09-30 $0.15B $0.08B 1.88
2023-06-30 $0.15B $0.08B 2.01
2023-03-31 $0.16B $0.08B 2.09
2022-12-31 $0.17B $0.12B 1.45
2022-09-30 $0.17B $0.10B 1.73
2022-06-30 $0.17B $0.08B 2.08
2022-03-31 $0.17B $0.07B 2.59
2021-12-31 $0.19B $0.08B 2.38
2021-09-30 $0.18B $0.07B 2.75
2021-06-30 $0.19B $0.07B 2.82
2021-03-31 $0.18B $0.06B 3.31
2020-12-31 $0.18B $0.06B 3.06
2020-09-30 $0.18B $0.05B 3.84
2020-06-30 $0.18B $0.04B 4.15
2020-03-31 $0.18B $0.05B 3.96
2019-12-31 $0.13B $0.05B 2.55
2019-09-30 $0.13B $0.05B 2.77
2019-06-30 $0.14B $0.05B 2.68
2019-03-31 $0.14B $0.05B 2.84
2018-12-31 $0.15B $0.05B 2.79
2018-09-30 $0.15B $0.04B 3.48
2018-06-30 $0.14B $0.03B 5.03
2018-03-31 $0.13B $0.02B 5.66
2017-12-31 $0.09B $0.02B 3.89
2017-09-30 $0.09B $0.02B 3.71
2017-06-30 $0.07B $0.03B 2.94
2017-03-31 $0.08B $0.03B 2.86
2016-12-31 $0.09B $0.03B 3.50
2016-09-30 $0.11B $0.02B 4.72
2016-06-30 $0.11B $0.03B 4.36
2016-03-31 $0.12B $0.02B 5.23
2015-12-31 $0.13B $0.02B 5.97
2015-09-30 $0.13B $0.02B 6.45
2015-06-30 $0.14B $0.02B 6.50
2015-03-31 $0.14B $0.02B 5.99
2014-12-31 $0.08B $0.03B 2.57
2014-09-30 $0.07B $0.02B 3.44
2014-06-30 $0.07B $0.02B 3.24
2014-03-31 $0.07B $0.03B 2.46
2013-12-31 $0.08B $0.04B 1.98
2013-09-30 $0.08B $0.04B 1.75
2013-06-30 $0.08B $0.03B 2.95
2013-03-31 $0.09B $0.03B 3.16
2012-12-31 $0.04B $0.03B 1.72
2012-09-30 $0.04B $0.03B 1.60
2012-06-30 $0.04B $0.02B 1.80
2012-03-31 $0.05B $0.03B 1.70
2011-12-31 $0.04B $0.02B 1.88
2011-09-30 $0.03B $0.01B 2.16
2011-06-30 $0.03B $0.02B 1.49
2011-03-31 $0.04B $0.02B 1.77
2010-12-31 $0.04B $0.02B 2.12
2010-09-30 $0.03B $0.02B 1.72
2010-06-30 $0.03B $0.01B 2.07
2010-03-31 $0.03B $0.01B 2.79
2009-12-31 $0.03B $0.01B 2.51
2009-09-30 $0.04B $0.02B 2.25
2009-06-30 $0.03B $0.01B 2.33
2009-03-31 $0.03B $0.01B 2.94
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.275B $0.180B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Medtronic (MDT) Ireland $112.813B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
Agilent Technologies (A) United States $34.235B 22.32
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Insulet (PODD) United States $21.023B 82.52
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Baxter (BAX) United States $16.278B 12.15
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00